Thrombocytopenia after chemotherapy for lymphoma
Conditions
Interventions
Haitripopa group:Haitripopa
Blank control group:None
Sponsors
Cancer Hospital Affiliated to Chongqing University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with various types of lymphoma clearly diagnosed by bone marrow puncture or pathological examination; 2. No chemotherapy contraindications were found, and the duration of chemotherapy was > 2 cycles; 3. The patients had a minimum platelet value =50*10^9/L but =2 points; Has received or is currently receiving radiation therapy, especially for long bones and flat bones (e.g. pelvis, sternum, etc.).; 4. Informed consent signed by the person or guardian.
Exclusion criteria
Exclusion criteria: 1. Chemotherapy contraindications exist; 2. Complicated with other malignant tumors; 3. Diseases of the immune system; 4. Severe cardiohepatic and renal impairment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CIT level occurred again;CIT duration; | — |
Secondary
| Measure | Time frame |
|---|---|
| The total amount of platelet transfused;Side effects;Relationship between the oral time of hetripopal and the occurrence of lymphoma CIT; | — |
Countries
China
Contacts
Public ContactXiao Chunyan
Cancer Hospital Affiliated to Chongqing University
Outcome results
None listed